Scientific work

Prof. Dr. Ahmet Taner Sümbül

127 publications. The source of the information is stated next to each publication.

Back to profile
  1. Clinicohistopathological features and treatment outcomes of neuroendocrine tumors: a single center experience

    Cukurova Medical Journal, 2018

    DOI 10.17826/cumj.335741 Open-access full textSource: ORCID

  2. Effect of adjuvant extended temozolamide treatment in survival of patients with glioblastoma multiforme

    Cukurova Medical Journal, 2018

    Source: ORCID

  3. Prognostic role of pretreatment level hemoglobin levels in patients with local advanced rectum cancer treated with preoperative chemotherapy

    Cukurova Medical Journal, 2018

    Source: ORCID

  4. Experience from Turkish centers participating in the Early Access Program (EAP): Preliminary real-world safety data of nivolumab (nivo) combined with ipilimumab (ipi) in pre-treated advanced melanoma patients

    Journal of Oncological Sciences, 2018

    DOI 10.1016/j.jons.2018.10.001 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  5. Conventıonal and targeted therapy in metastatıc colorectal cancer

    Journal of Cancer Prevention & Current Research, 2018

    DOI 10.15406/jcpcr.2018.09.00369 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  6. Hepatotoxicity and Hepatic Dysfunction

    Springer eBooks, 2018

    DOI 10.1007/978-3-319-90990-5_30 1 citation (OpenAlex) Source: OpenAlex

  7. Impact of metastasis status on abireteron outcomes in patients with metastatic castration resistant prostate cancer

    European Urology Supplements, 2018

    DOI 10.1016/s1569-9056(18)33730-8 Source: OpenAlex

  8. Effectiveness of bendamustine in relapse or refractory lymphoma cases: A report from Turkey-The Turkish Oncology Group (TOG) study

    Journal of Clinical Oncology, 2017

    DOI 10.1200/jco.2017.35.15_suppl.e19027 Source: ORCID

  9. Influence of Creatinine Clearance on Survival Parameters in Small Cell Lung Cancer Treated with Cisplatin-Based Chemotherapy Regimen

    Journal of Thoracic Oncology, 2017

    Source: ORCID

  10. The analysis of lncRNA HOTAIR rs12826786 C>T polymorphism and gastric cancer susceptibility in a Turkish population: lack of any association in a hospital-based case–control study

    Irish Journal of Medical Science, 2017

    DOI 10.1007/s11845-017-1596-x PMID 28342055 16 citations (Europe PMC) Source: ORCID

  11. Unexpected skin lesions after axitinib treatment

    Journal of Oncological Sciences, 2017

    DOI 10.1016/j.jons.2017.05.003 5 citations (OpenAlex) Open-access full textSource: OpenAlex

  12. P1.07-010 Influence of Creatinine Clearance on Survival Parameters in Small Cell Lung Cancer Treated with Cisplatin-Based Chemotherapy Regimen

    Journal of Thoracic Oncology, 2017

    DOI 10.1016/j.jtho.2016.11.921 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  13. Preoperatif kemoradyoterapi uygulanan lokal ileri rektum kanserli hastalarda tedavi öncesi hemoglobin düzeyinin prognozdaki rolü

    Çukurova medical journal (Online)/Çukurova medical journal, 2017

    DOI 10.17826/cumj.335761 Open-access full textSource: OpenAlex

  14. Prognostic value of procalcitonin in infection-related mortality of cancer patients.

    Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 2016

    PMID 27569098 2 citations (Europe PMC) Source: ORCID

  15. Polymorphisms in human telomerase reverse transcriptase (hTERT) gene and susceptibility to gastric cancer in a Turkish population: Hospital-based case-control study.

    Gene, 2016

    DOI 10.1016/j.gene.2016.03.030 PMID 27016301 18 citations (Europe PMC) Source: ORCID

  16. Morpho-pomological diversity of Turkish pear (Pyrus communis L.) accessions in eastern mediterranean region of Turkey,Morfologiczna i pomologiczna różnorodność Tureckich odmian gruszy (Pyrus communis L.) we wschodnim śródziemnomorskim rejonie Turcji

    Acta Scientiarum Polonorum, Hortorum Cultus, 2016

    Source: ORCID

  17. Acute fatal interstitial lung disease in two cases under treatment of crizotinib

    Clinical Case Reports and Reviews, 2016

    DOI 10.15761/ccrr.1000250 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  18. Renal Hücreli Kanserde Hedefe Yönelik Tedaviler

    Turkiye Klinikleri Medical Oncology - Special Topics, 2016

    Source: OpenAlex

  19. Endokrin Bozucular ve Onkolojik Hastalıklar

    Turkiye Klinikleri Endocrinology - Special Topics, 2016

    Source: OpenAlex

  20. Can primary tumor localization predict the which patient will have benefit from addition of taxanes to platin-5-FU based regimens in metastatic gastric cancer. Multi center retrospective analysis from Turkey, Society of Turkish Oncology Group study.

    Journal of Clinical Oncology, 2015

    DOI 10.1200/jco.2015.33.15_suppl.e15030 Source: OpenAlex

  21. Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumab.

    Breast (Edinburgh, Scotland), 2015

    DOI 10.1016/j.breast.2015.11.006 PMID 26801412 23 citations (Europe PMC) Source: ORCID

  22. A functional HOTAIR rs920778 polymorphism does not contributes to gastric cancer in a Turkish population: a case-control study.

    Familial cancer, 2015

    DOI 10.1007/s10689-015-9813-0 PMID 25980897 42 citations (Europe PMC) Source: ORCID

  23. A functional HOTAIR rs12826786 C>T polymorphism is associated with breast cancer susceptibility and poor clinicopathological characteristics in a Turkish population: a hospital-based case-control study.

    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2015

    DOI 10.1007/s13277-015-4430-y PMID 26577852 38 citations (Europe PMC) Source: ORCID

  24. MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study.

    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2015

    DOI 10.1007/s13277-015-3708-4 PMID 26152286 18 citations (Europe PMC) Source: ORCID

  25. Concurrent chemoradiotherapy with vinorelbine plus split-dose cisplatin may be an option in inoperable stage III non-small cell lung cancer: a single-center experience.

    Medical science monitor : international medical journal of experimental and clinical research, 2015

    DOI 10.12659/msm.892730 PMID 25731741 5 citations (Europe PMC) Open-access full textSource: ORCID

  26. Effect of HOTAIR rs920778 polymorphism on breast cancer susceptibility and clinicopathologic features in a Turkish population.

    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2015

    DOI 10.1007/s13277-014-3028-0 PMID 25586347 71 citations (Europe PMC) Source: ORCID

  27. Patients with distal intestinal gastric cancer have superior outcome with addition of taxanes to combination chemotherapy, while proximal intestinal and diffuse gastric cancers do not: does biology and location predict chemotherapy benefit?

    Medical oncology (Northwood, London, England), 2015

    DOI 10.1007/s12032-014-0476-8 PMID 25572818 3 citations (Europe PMC) Source: ORCID

  28. Determination of Phthalates Migrating from Plastic Containers into Beverages

    Food Analytical Methods, 2015

    DOI 10.1007/s12161-014-9896-5 38 citations (OpenAlex) Source: ORCID

  29. High Pretreatment Neutrophil-Lymphocyte Ratio: A Poor Prognostic Factor for Stage III Non-Small Cell Lung Cancer Patients

    Journal of Thoracic Oncology, 2015

    Source: ORCID

  30. Prognostic Role of fox-p3 Positive T-Regulatory Cells in Curatively Resected NSCLC Other than Stage IA

    Journal of Thoracic Oncology, 2015

    Source: ORCID

  31. CONCURRENT CHEMORADIOTHERAPY WITH VINORELBINE PLUS SPLIT-DOSE CISPLATIN IN INOPERABLE STAGE III NON-SMALL CELL LUNG CANCER

    Annals of Oncology, 2015

    DOI 10.1093/annonc/mdv049.10 Open-access full textSource: ORCID

  32. PROGNOSTIC ROLE OF T-REGULATORY CELLS IN COMPLETELY RESECTED EARLY STAGE NON-SMALL CELL LUNG CARCINOMA

    Annals of Oncology, 2015

    DOI 10.1093/annonc/mdv048.11 Open-access full textSource: ORCID

  33. Contribution of a functional polymorphism in HOTAIR to the susceptibility of gastric cancer in a Turkish population: A case-control study.

    Journal of Clinical Oncology, 2015

    DOI 10.1200/jco.2015.33.15_suppl.e15100 Source: OpenAlex

  34. J Clin Hypertens (Greenwich) 2011 Diel U

    2014

    Source: OpenAlex

  35. A case of rectal adenocarcinoma presented with palatine tonsil metastasis.

    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2014

    DOI 10.1177/1078155214565124 PMID 25538162 3 citations (Europe PMC) Source: ORCID

  36. Gemcitabine + platinum combination chemotherapy in patients with metastatic cancer who suffer from severe and irreversible hepatic impairment: a single center experience.

    Hepato-gastroenterology, 2014

    PMID 25713885 Source: ORCID

  37. miR-204-5p expression in colorectal cancer: an autophagy-associated gene.

    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2014

    DOI 10.1007/s13277-014-2596-3 PMID 25209181 37 citations (Europe PMC) Source: ORCID

  38. An old enemy not to be forgotten during PET CT scanning of cancer patients: tuberculosis.

    Contemporary oncology (Poznan, Poland), 2014

    DOI 10.5114/wo.2014.43985 PMID 27358601 3 citations (Europe PMC) Open-access full textSource: ORCID

  39. Continuous distress in an oncology clinic in Turkey: should we make use of the distress thermometer mandatory as a precautionary measure for physicians?

    Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 2014

    PMID 25261671 1 citation (Europe PMC) Source: ORCID

  40. Malignant pleural mesothelioma: a single-center experience in Turkey.

    Medical science monitor : international medical journal of experimental and clinical research, 2014

    DOI 10.12659/msm.890020 PMID 24842043 5 citations (Europe PMC) Open-access full textSource: ORCID

  41. Evaluation of mean platelet volume in patients with type 2 diabetes mellitus and blood glucose regulation: a marker for atherosclerosis?

    International journal of clinical and experimental medicine, 2014

    PMID 24955167 39 citations (Europe PMC) Open-access full textSource: ORCID

  42. Being a medical oncologist near the war area.

    Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 2014

    PMID 24965429 Source: ORCID

  43. Can serial monitoring of serum Vascular Endothelial Growth Factor (VEGF), Nitric Oxide (NO), and Angiotensin II (ANGII) levels have predictive role during Bevacizumab treatment?

    Medical science monitor : international medical journal of experimental and clinical research, 2014

    DOI 10.12659/msm.889945 PMID 24632679 4 citations (Europe PMC) Open-access full textSource: ORCID

  44. Investigation of neutrophil lymphocyte ratio and blood glucose regulation in patients with type 2 diabetes mellitus.

    The Journal of international medical research, 2014

    DOI 10.1177/0300060513516944 PMID 24567354 76 citations (Europe PMC) Open-access full textSource: ORCID

  45. Neutrophil-to-lymphocyte ratio predicts PSA response, but not outcomes in patients with castration-resistant prostate cancer treated with docetaxel.

    International urology and nephrology, 2014

    DOI 10.1007/s11255-014-0664-7 PMID 24526335 19 citations (Europe PMC) Source: ORCID

  46. Low serum levels of vitamin D in metastatic cancer patients: a case-control study.

    Medical oncology (Northwood, London, England), 2014

    DOI 10.1007/s12032-014-0861-3 PMID 24493144 4 citations (Europe PMC) Source: ORCID

  47. Can low molecular weight heparins circumvent the problem of coumadine and chemotherapy interaction in cancer patients with prosthetic heart valves?

    Asian Pacific journal of cancer prevention : APJCP, 2014

    DOI 10.7314/apjcp.2014.15.4.1889 PMID 24641426 1 citation (Europe PMC) Open-access full textSource: ORCID

  48. Is it rational to continue anti-neoplastics with minimal toxicity even after progression in patients with no other options? Possibly yes.

    Asian Pacific journal of cancer prevention : APJCP, 2014

    DOI 10.7314/apjcp.2014.15.2.1061 PMID 24568451 Open-access full textSource: ORCID

  49. Diffuse osteosclerosis in a patient with prostate cancer

    Osteoporosis International, 2014

    DOI 10.1007/s00198-013-2545-9 PMID 24136106 5 citations (Europe PMC) Source: ORCID

  50. Effect of GM-CSF levels on osteoporosis in postmenopausal period

    Acta Medica Mediterranea, 2014

    Source: ORCID